HNGE holder files Rule 144 to sell 351,045 Class A shares

HNGE has a shareholder filing a Rule 144 notice to sell 351,045 Class A shares through Merrill Lynch on the NYSE, with an approximate sale date of 11/18/2025.

Rhea-AI Filing Summary

HNGE has a shareholder filing a Rule 144 notice to sell 351,045 Class A shares through Merrill Lynch on the NYSE, with an approximate sale date of 11/18/2025.

The filing lists an aggregate market value of 14,336,677.8 for the shares to be sold and notes that 37,919,155 shares were outstanding. The shares were originally acquired from the issuer in a private placement on 02/04/2020 for cash. The signer represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HNGE Form 144 filing disclose?

The filing discloses that a holder of HNGE Class A stock intends to sell 351,045 shares under Rule 144 through Merrill Lynch on the NYSE, with an approximate sale date of 11/18/2025.

How many HNGE shares are planned to be sold under this Form 144?

The notice states that 351,045 Class A shares of HNGE are planned to be sold, with an aggregate market value of 14,336,677.8 at the time of the filing.

How many HNGE shares were outstanding when this Form 144 was prepared?

The Form 144 indicates that 37,919,155 shares of HNGE Class A stock were outstanding when the notice was prepared.

How and when were the HNGE shares being sold originally acquired?

According to the filing, the 351,045 Class A shares were acquired from the issuer in a private placement on 02/04/2020, and the consideration was paid in cash on the same date.

Which broker is handling the proposed HNGE share sale under Rule 144?

The Form 144 lists Merrill Lynch, located at One Bryant Park, New York, NY 10036, as the broker for the planned sale of HNGE Class A shares on the NYSE.

What representation does the seller make in the HNGE Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about HNGE’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/18/2025 - 04:56 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001748910
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET, 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Bessemer Venture Partners X Institutional LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	351045	14336677.8	37919155	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/04/2020	Private Placement	Issuer			351045	02/04/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Augie Wilkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)